| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $159.5M | — | -1.9% |
| Cost of Revenue | $66.8M | — | +3.9% |
| Gross Profit | $92.7M | — | -5.7% |
| R&D Expense | $16.6M | — | +6.0% |
| SG&A Expense | $16.9M | — | +1.3% |
| Operating Income | $22.9M | — | -22.0% |
| Pre-tax Income | $25.1M | — | -23.1% |
| Income Tax | $4.8M | — | -45.3% |
| Net Income | $20.3M | — | -15.0% |
| EPS (Basic) | $0.10 | — | -9.1% |
| EPS (Diluted) | $0.10 | — | -9.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $236.5M | -7.7% | -6.2% |
| Short-term Investments | $19.2M | -1.3% | -81.7% |
| Accounts Receivable | $67.7M | -26.4% | -6.4% |
| Inventory | $114.2M | +0.6% | -15.0% |
| Current Assets | $461.9M | -7.5% | -17.7% |
| Total Assets | $543.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $26.9M | — | -56.1% |
| Investing Cash Flow | -$9.1M | — | -86.6% |
| Financing Cash Flow | -$37.4M | — | -2.7% |
| -20.2% |
| Current Liabilities | $169.9M | -23.2% | -0.6% |
| Total Liabilities | $186.3M | -21.5% | -2.7% |
| Stockholders' Equity | $357.5M | +4.1% | -27.1% |